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Murine tumor cells (1-3) and certain murine retroviruses (4) contain factors 
that inhibit macrophage (M~b) accumulation at inflammatory foci. The retroviral 
activity is contained in the envelope protein P15E (4).  P15E also inhibits lym- 
phoproliferative responses  of cats  and  man  (5,  6).  We  recently showed  that 
spontaneous and carcinogen-induced murine malignant cells synthesize a protein 
that is physicochemically  and antigenically similar to P 15E. The inhibitory activity 
for M(b accumulation in the tumors was removed by monoclonal anti-P 15E (7). 
Human cancerous effusions also contain proteins that inhibit human monocyte 
responses to chemoattractants and the inhibitory activity was absorbed by mono- 
clonai anti-P 15E (8). We now sought to determine whether P 15E-related antigens 
are indeed present in human malignant cells. 
Materials and Methods 
Cells.  The cell lines studied,  U937,  K562,  SB,  MOLT-4,  HL60, HL60-BII, HSB-2, 
and CEM, were all  derived  from humans with lymphoid neoplasms and obtained from 
the  American  Type  Culture  Collection,  Rockville,  MD.  The  U937  line  was  from  a 
histiocytic  lymphoma.  The  HL60  and  the  HL60  BII  subclone  were  from  an  acute 
promyelocytic leukemia. The T  lymphoblastoid HSB-2 and the B lymphoblastoid SB cell 
lines were from a patient with acute lymphoblastic leukemia. The T  lymphoblastoid CEM 
and MOLT-4 lines were derived from acute lymphoblastic leukemias. The K562 line was 
from a chronic myelogenous leukemia effusion. All cell lines tested (HL60, HSB, CEM, 
MOLT-4,  K562)  grew  as  tumors  in  animal  models.  Control  mononuclear  cells  were 
isolated  from normal  human  blood  with  Lymphocyte Separation  Media  (8).  Cell  lines 
were grown in  RPMI  1640  with  10%  heated  fetal bovine serum and antibiotics (Gibco 
Laboratories, Grand Island, NY). 
Antibodies.  Monoclonal  antibodies  19F8  (IgG~b)  and  4F5(IgG~a),  which  react  with 
different epitopes on murine retroviral  P15E, were contained in ascites fluid or Protein 
A purified from ascites or hybridoma culture supernatants (7, 9). Control antibodies were 
pooled normal mouse serum (NMS) or Protein A-purified IgG~b or IgGea from culture 
supernatants of the MPC11  OUA or RPC 5.4 cell lines (American Type Culture Collec- 
tion, Rockville, MD). 
Indirect tmmunofluorescence.  Cells were fixed on ice using phosphate-buffered (pH 7.2) 
saline (PBS) containing 45%  acetone, and 9.25%  formaldehyde, washed, and incubated 
with  antibody  (final  concentration  =  1:40-1:100  ascites  or  NMS;  50.0-125.0  #g/ml 
This work was supported by National Cancer Institute grant #P01-CA-29589-02.  Reprint requests 
should  be addressed  to G. J. Cianciolo,  Box 3892, Duke  University  Medical Center, Durham, NC 
2771O. 
964  J. ExP. MED. © The Rockefeller University Press • 0022-1007/84/03/0964/06 $1.00 
Volume 159  March  1984  964-969 CIANC1OLO  ET  AL.  BRIEF  DEFINITIVE  REPORT  965 
g..I 
Z 
UJ  LJ 
PBMC 
C~ 
0937  HL60  ~  BI[ 
LOG  FLUORESCENCE 
FIGURE  1.  Anti-P15E  reactivity  of human  malignant  and  normal  mononuclear  cells.  Cells 
were  fixed,  incubated  with  12.5  ~tg  of anti-P15E  19F8  or  IgG~b,  stained,  and  analyzed  by 
FACS. For each cell type the less fluorescent histogram  represents  cells incubated  with control 
IgG2b. 
TABLE  I 
Fluorescence Reactivity of Monoclonal Anti-P15E Antibodies with Human Cell Lines* 
Cells  n! 
tested* 
Antibodies used  Antibodies used 
?/ 
Anti-P15E,  Control!  Anti-Pl 5E, 4F5  Control  ~ 
19F8 
%±SD  %±SD 
U937  14  74.9 -+ 9.8  5.5 --. 3.8  2  70.2 ±  25.7  15.2 ±  2.3 
HL60  6  56.3 +  9.0  5.2 -+ 3.5  2  64.3 -+ 0.6  26.2 ±  11.8 
HL60 BII  6  64.2±  19.1  6.8-+4.6  NT  --  -- 
CEM  5  40.4 --. 28.4  7.6 ±  8.6  NT  --  -- 
K562  5  79.5 ±  16.3  20.2 ±  9.4  2  57.2 ±  41.8  20.1 +  3.2 
HSB-2  3  54.6 -+ 21.2  7.7 -+ 7.8  2  35.0 +  15.3  6.1 ±  4.5 
SB  4  65.2-+14.9  18.0±8.1  2  67.7-+16.4  14.4-+0.8 
MOLT-4  2  76.0 -+ 0.8  14.4 -+ 1.6  2  29.4 -+ 1.5  4.6 ±  3.5 
PBMC  14  7.2 -+ 4.3  1.4 ±  1.2  3  6.1 -+ 10.6  1.7 -+ 2.9 
* Fluorescence was measured on  10,000 fixed cells as described in Materials and Methods. The photomultiplier 
tube setting was adjusted so that -5%  of the PBMC were fluorescent with anti-P 15E. Anti-P 15E(19F8) was used 
at a  l:40-h100  dilution of ascites fluid or as 62.5-125.0 #g/ml of antibody isolated from ascites fluid or culture 
supernatants by Protein A  Sepharose. Anti-P15E (4F5) was used as 50.0 #g/ml of antibody isolated from culture 
supernatants by Protein A  Sepharose. 
* Cells were obtained as described in Materials and Methods. 
! No. of times the cells were examined. 
! Control antibody was either NMS used at a  1:40-1:100 dilution or 62.5-125.0 #g/ml of IgG~b purified from 
ascites fluid or culture supernatants of the MPC11 OUA cell line. 
I Control antibody was 50.0 tag/ml of IgG~ isolated from culture supernatants of the RPC 5.4 cell line. 
purified  Ig) for  20  min  on  ice,  washed,  incubated on  ice  with  FITC-conjugated goat 
F(ab')2 anti-mouse IgG (1 : 100, Tago, Burlingame, CA), washed with PBS/5 % goat serum, 
and 10,000 cells analyzed using a Coulter EPICS fluorescence-activated cell sorter (FACS). 
Full scale fluorescence was 1.5 log. 
Mitogen Stimulation.  Isolated normal mononuclear cells were resuspended to 2 ×  106 
lymphocytes/ml in supplemented RPMI. Cells (1  ml) were cultured with media alone or 
with PHA (0.5 ~tg/ml),  Con A (5.0 #g/ml), or PWM (1:250 dilution of stock) at 37°C in a 
humidified, 5% CO2 atmosphere, and prepared for immunofluorescence as above. 
Reagents.  Bovine serum albumin Fraction V (BSA) and dibutyrl cyclic AMP (dbcAMP) 
were  from Sigma Chemical  Co.  St.  Louis,  MO.  Phytohemagglutinin  (PHA) was from 966  CIANCIOLO  ET  AL. 
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FIGURE 2.  (A) Effect of cellular differentiation on anti-P15E reactivity. Cells were differen- 
tiated by culturing with dbcAMP, fixed, incubated with  12.5 #g of anti-P15E  19F8, stained, 
and analyzed  by  FACS. The histograms  of dbcAMP  treated  cells are indicated by Tx.  (B) 
Effect of mitogen stimulation on anti-P 15E reactivity of human mononuclear cells. Cells were 
cultured for 48 h with the indicated mitogens, washed, fixed, incubated with 12.5 ug of anti- 
P15E  19F8 or IgG2b, stained, and analyzed by FACS. For each mitogen the less fluorescent 
histogram represents cells incubated with control IgG2b. 
Burroughs Wellcome, Inc., Greenville, NC, concanavalin A (Con A) from Pharmacia Fine 
Chemicals, Piscataway, N  J, and pokeweed mitogen (PWM) from Gibco. 
Results 
Reactivity of Human  Tumor Cell Lines with Anti-P15E.  Cell lines were examined 
for anti-P15E reactivity by indirect immunofluorescence and FACS analysis. The 
photomultiplier tube setting was adjusted so that ~5% of freshly isolated mono- 
nuclear cells were reactive with anti-P 15E. All cell lines reacted with the purified 
anti-P15E (Fig.  1 and Table I).  For each tumor cell line there was a significant 
difference between the fluorescence of cells incubated with either of the mono- 
clonal anti-P 15E antibodies compared with those incubated with control antibod- 
ies.  The difference in anti-P15E reactivity between normal mononuclear cells 
and malignant cells was not due to cell size (data not shown). 
Effect of Cellular Differentiation  on Anti-Pl5E  Reactivity.  The effects of differ- 
entiation on the ability of U937,  HL60, and HL60 BII cells  to bind anti-P15E 
was examined. Cell lines were grown in 0.5 mM dbcAMP for 48 h, conditions 
which  induce  differentiation and  enhance  mature  leukocyte functions in  the 
U937 and HL60 but not in the HL60 BII cell line (10-12). Treatment of U937 
and HL60 with dbcAMP caused a  decrease in the anti-P15E reactivity of the 
cells  (Fig.  2A).  In  four experiments the average decreases in reactivity of the CIANC1OLO  ET  AL.  BRIEF  DEFINITIVE  REPORT  967 
dbcAMP-treated U937 and HL60 cells were 53.8  (37.1-85.3) and 35.8  (10.5- 
60.6) percent, respectively. Treatment of HL60 BII cells with dbcAMP had no 
effect on the anti-P15E reactivity. In five experiments the average decrease in 
reactivity was 3.4%. The decrease in fluorescence in differentiated cells was not 
due to a change in cell size, but to both decreased numbers of fluorescent cells 
and decreased intensity of fluorescence (data not shown). 
Effect  of Mitogen  Stimulation  on  Anti-P15E  Reactivity  of Normal  Human  Blood 
Mononuclear  Cells.  Fresh mononuclear cells had little reactivity with anti-P15E. 
To determine the effects of blast transformation, they were cultured with PHA, 
Con A, or PWM for 48-72  h. The mitogens all induced the cells to react with 
anti-P15E  (Fig.  2B).  In  four  experiments  the  percentages  of PHA-  or  Con 
A-stimulated cells reacting with  anti-P15E  were  58.6  (4-  10.8  SD) and  37.5 
(4-  12.9 SD), respectively, compared with  11.4 (4- 5.6 SD) and  10.0 (4- 8.5 SD) 
with control immunoglobulin. In a single experiment the percentages of PWM- 
stimulated cells reacting with anti-P15E or control antibody were 46.8 and 20.3, 
respectively. The increase in reactivity was not due to nonspecific sticking of the 
antibody to the lectins (data not shown). 
Discussion 
All of the malignant cell lines examined reacted with two monoclonal antibod- 
ies to independent epitopes of retroviral P 15E. The internal nature of this P 15E- 
related antigen is indicated by its being detected only in permeabilized cells. The 
fixation process per se was unlikely to cause anti-P15E reactivity, since different 
fixation  processes  (formalin  vs.  glutaraldehyde-paraformaldehyde)  worked 
equally well (data not shown). Interestingly, two other proteins associated with 
malignant cells,  the p60 src and p21  proteins of Rous and  Harvey sarcoma vi- 
rus-transformed cells,  have also been reported to  be internally localized (13, 
14). 
The  loss  of anti-P15E  reactivity with dbcAMP differentiation of malignant 
cells and the increase in  reactivity in  mitogen-transformed mononuclear cells 
suggest that the synthesis of the P15E-related antigen may be controlled by a 
gene that is either not expressed, or is expressed at very low levels in differen- 
tiated cells, but whose expression increases during rapid cell growth. Indeed, the 
p53 protein has been reported in elevated amounts in a wide variety of neoplast- 
ically transformed cells  and  to  increase  in  mitogen-stimulated cells  (15,  16). 
Although we have not yet isolated and characterized the P15E-related antigen 
from human cells the possibility that it, like its murine counterpart, has immu- 
nosuppressive properties, would have important theoretical implications. Recent 
reports have indicated that human DNA contains sequences that hybridize with 
murine leukemia virus cDNA probes (17). Furthermore, human malignant cells 
contain oncogenes that are capable of inducing neoplastic transformation in vitro 
(18).  The  expression  by  transformed cells  of additional  genes  that  code  for 
immunosuppressive proteins such as P! 5E would be likely to confer a selective 
advantage upon such ceils for sustained growth. Thus neoplastic transformation, 
sufficient to allow sustained tumor growth in  situ,  may be a  multistep process 
involving expression of genes regulating not only cellular transformation, but 
immunosuppressive properties as well. 968  CIANCIOLO  ET  AL.  BRIEF  DEFINITIVE  REPORT 
Summary 
Virus-related  oncogenes have been demonstrated in human tumor cells and 
may play a role in neoplastic transformation. Cancerous effusions contain inhib- 
itors of monocyte function and are absorbed by monoclonal antibodies to the 
immunosuppressive retroviral structural protein, P 15E. We therefore examined 
eight human malignant cell lines for P15E-related  antigens, by indirect immu- 
nofluorescence.  Up  to  87%  of fixed  malignant  cells  were  reactive  with  two 
different monoclonal anti-P 15E antibodies, while under identical conditions ~7 % 
of freshly isolated human mononuclear cells were positive. Differentiation of two 
tumor  cell  lines  with  dibutyrl  cyclic  AMP  resulted  in  decreased  anti-P15E 
reactivity.  Blast  transformation  of  human  mononuclear  cells  with  mitogens 
induced reactivity with anti-P15E. Thus human malignant and blast-transformed 
cells contain antigens related to P15E. Expression of this viral-related gene may 
occur during rapid cell division and be abnormally regulated in cancer cells, thus 
rendering them more resistant to immune destruction. 
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